Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.
Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, Guardalben E, Liberatore C, Faraci D, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. Blood. 2017 Jun 29;129(26):3495-3498. doi: 10.1182/blood-2017-03-772285. Epub 2017 Apr 26. Blood. 2017. PMID: 28446433 Free article. No abstract available.
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
Rigolin GM, Formigaro L, Cavallari M, Quaglia FM, Lista E, Urso A, Guardalben E, Martinelli S, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. Oncotarget. 2017 Apr 25;8(17):28008-28020. doi: 10.18632/oncotarget.15883. Oncotarget. 2017. PMID: 28427204 Free PMC article.
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.
Rigolin GM, Saccenti E, Guardalben E, Cavallari M, Formigaro L, Zagatti B, Visentin A, Mauro FR, Lista E, Bassi C, Lupini L, Quaglia FM, Urso A, Bardi MA, Bonaldi L, Volta E, Tammiso E, Ilari C, Cafforio L, Melandri A, Cavazzini F, Negrini M, Semenzato G, Trentin L, Foà R, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. Br J Haematol. 2018 Apr;181(2):229-233. doi: 10.1111/bjh.15174. Epub 2018 Apr 2. Br J Haematol. 2018. PMID: 29611195 Free article.
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.
Rigolin GM, Saccenti E, Melandri A, Cavallari M, Urso A, Rotondo F, Betulla A, Tognolo L, Bardi MA, Rossini M, Tammiso E, Bassi C, Cavazzini F, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. Br J Haematol. 2021 Mar;192(6):1068-1072. doi: 10.1111/bjh.16865. Epub 2020 Jun 24. Br J Haematol. 2021. PMID: 32578873 Free article. Clinical Trial.
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.
Rigolin GM, Saccenti E, Rizzotto L, Ferracin M, Martinelli S, Formigaro L, Cibien F, Cavallari M, Lista E, Daghia G, Sofritti O, Ciccone M, Cavazzini F, Lupini L, Bassi C, Zagatti B, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. Oncotarget. 2014 Jan 15;5(1):140-9. doi: 10.18632/oncotarget.1382. Oncotarget. 2014. PMID: 24334759 Free PMC article.
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
Rigolin GM, del Giudice I, Formigaro L, Saccenti E, Martinelli S, Cavallari M, Lista E, Tammiso E, Volta E, Lupini L, Bassi C, Bardi A, Sofritti O, Daghia G, Cavazzini F, Marinelli M, Tavolaro S, Guarini A, Negrini M, Foà R, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. Genes Chromosomes Cancer. 2015 Dec;54(12):818-26. doi: 10.1002/gcc.22293. Epub 2015 Sep 10. Genes Chromosomes Cancer. 2015. PMID: 26355802
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion.
Cavazzini F, Lista E, Quaglia FM, Formigaro L, Cavallari M, Martinelli S, Rigolin GM, Foà R, Cuneo A. Cavazzini F, et al. Among authors: cavallari m. Leuk Lymphoma. 2016 Nov;57(11):2685-8. doi: 10.3109/10428194.2016.1154955. Epub 2016 Mar 21. Leuk Lymphoma. 2016. PMID: 26999572 No abstract available.
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM, Saccenti E, Bassi C, Lupini L, Quaglia FM, Cavallari M, Martinelli S, Formigaro L, Lista E, Bardi MA, Volta E, Tammiso E, Melandri A, Urso A, Cavazzini F, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: cavallari m. J Hematol Oncol. 2016 Sep 15;9(1):88. doi: 10.1186/s13045-016-0320-z. J Hematol Oncol. 2016. PMID: 27633522 Free PMC article.
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia.
Cavallari M, Cavazzini F, Bardi A, Volta E, Melandri A, Tammiso E, Saccenti E, Lista E, Quaglia FM, Urso A, Laudisi M, Menotti E, Formigaro L, Dabusti M, Ciccone M, Tomasi P, Negrini M, Cuneo A, Rigolin GM. Cavallari M, et al. Oncotarget. 2018 Sep 28;9(76):34398-34412. doi: 10.18632/oncotarget.26146. eCollection 2018 Sep 28. Oncotarget. 2018. PMID: 30344950 Free PMC article. Review.
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Visentin A, Bonaldi L, Rigolin GM, Mauro FR, Martines A, Frezzato F, Imbergamo S, Scomazzon E, Pravato S, Bardi MA, Cavallari M, Volta E, Cavazzini F, Nanni M, Del Giudice I, Facco M, Guarini A, Semenzato G, Foà R, Cuneo A, Trentin L. Visentin A, et al. Among authors: cavallari m. Br J Cancer. 2019 Jul;121(2):150-156. doi: 10.1038/s41416-019-0502-x. Epub 2019 Jun 18. Br J Cancer. 2019. PMID: 31209327 Free PMC article.
132 results